{"created_at":"Mon Feb 09 04:22:58 +0000 2015","id":564640576708952064,"id_str":"564640576708952064","text":"RT @JNTNews: Ahh, hahh, $JNJ Johnson &amp; Johnson promotes financially incompetent to CFO ;o)\nhttp:\/\/t.co\/K70RPJszlr\nFinancial catastrophe wai\u2026","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2550575082,"id_str":"2550575082","name":"diane schuricht","screen_name":"sudischuricht","location":"","url":null,"description":null,"protected":false,"verified":false,"followers_count":97,"friends_count":124,"listed_count":3,"favourites_count":775,"statuses_count":3449,"created_at":"Fri Jun 06 17:40:27 +0000 2014","utc_offset":null,"time_zone":null,"geo_enabled":true,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/513061016284852224\/7JGTBsuJ_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/513061016284852224\/7JGTBsuJ_normal.jpeg","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Mon Feb 09 04:12:47 +0000 2015","id":564638014807490560,"id_str":"564638014807490560","text":"Ahh, hahh, $JNJ Johnson &amp; Johnson promotes financially incompetent to CFO ;o)\nhttp:\/\/t.co\/K70RPJszlr\nFinancial catastrophe waiting to happen","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":529121515,"id_str":"529121515","name":"Johnson and Toxin","screen_name":"JNTNews","location":"A park bench :)","url":"http:\/\/www.johnsonandtoxin.com","description":"Dedicated to exposing and ending corruption at Johnson & Johnson which results in KNOWN harmful consumer products.","protected":false,"verified":false,"followers_count":763,"friends_count":570,"listed_count":19,"favourites_count":484,"statuses_count":11424,"created_at":"Mon Mar 19 05:14:25 +0000 2012","utc_offset":null,"time_zone":null,"geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"1F0502","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme9\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme9\/bg.gif","profile_background_tile":false,"profile_link_color":"5D0000","profile_sidebar_border_color":"FFFFFF","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/543190724032724992\/G26fctzy_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/543190724032724992\/G26fctzy_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/529121515\/1421810820","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":1,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/K70RPJszlr","expanded_url":"http:\/\/www.johnsonandtoxin.com\/dominic_caruso_profile.shtml","display_url":"johnsonandtoxin.com\/dominic_caruso\u2026","indices":[82,104]}],"user_mentions":[],"symbols":[{"text":"JNJ","indices":[11,15]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/K70RPJszlr","expanded_url":"http:\/\/www.johnsonandtoxin.com\/dominic_caruso_profile.shtml","display_url":"johnsonandtoxin.com\/dominic_caruso\u2026","indices":[95,117]}],"user_mentions":[{"screen_name":"JNTNews","name":"Johnson and Toxin","id":529121515,"id_str":"529121515","indices":[3,11]}],"symbols":[{"text":"JNJ","indices":[24,28]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1423455778659"}
{"created_at":"Mon Feb 09 17:22:58 +0000 2015","id":564836870127755264,"id_str":"564836870127755264","text":".@BioRunUp (or anyone else) Do you know of any company that's gotten CHMP recommendation and not EC approval besides $JNJ's Zeftera?","source":"\u003ca href=\"http:\/\/twitter.com\" rel=\"nofollow\"\u003eTwitter Web Client\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":564816491174825984,"in_reply_to_status_id_str":"564816491174825984","in_reply_to_user_id":102527566,"in_reply_to_user_id_str":"102527566","in_reply_to_screen_name":"BioRunUp","user":{"id":26117527,"id_str":"26117527","name":"Brian Orelli","screen_name":"BiologyFool","location":"San Diego","url":"http:\/\/www.linkedin.com\/in\/brianorelli","description":"Freelance writer\/analyst for The Motley Fool, BioWorld, Nature Biotechnology, and anyone else that will let me write at the intersection of drugs and business.","protected":false,"verified":false,"followers_count":2711,"friends_count":847,"listed_count":93,"favourites_count":325,"statuses_count":854,"created_at":"Mon Mar 23 23:16:02 +0000 2009","utc_offset":-28800,"time_zone":"Pacific Time (US & Canada)","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/1153506722\/100_1965-1_normal.JPG","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/1153506722\/100_1965-1_normal.JPG","default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[],"user_mentions":[{"screen_name":"BioRunUp","name":"BioRunUp","id":102527566,"id_str":"102527566","indices":[1,10]}],"symbols":[{"text":"JNJ","indices":[117,121]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1423502578657"}
{"created_at":"Mon Feb 09 21:33:59 +0000 2015","id":564900040565477377,"id_str":"564900040565477377","text":"Going Overweight With Gilead In My DGI Portfolio http:\/\/t.co\/rGi3wwDwmU $ABBV $BCR $BDX $JNJ $MDT $MSA $WBA $GILD","source":"\u003ca href=\"http:\/\/seekingalpha.com\" rel=\"nofollow\"\u003eSeeking Alpha\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":2999760448,"id_str":"2999760448","name":"Healthcare Stocks","screen_name":"SA_HealthInvest","location":"","url":"http:\/\/seekingalpha.com\/news\/healthcare","description":"Seeking Alpha's breaking news and analysis of healthcare stocks. For all SA Twitter feeds, see https:\/\/twitter.com\/SeekingAlpha\/following","protected":false,"verified":false,"followers_count":79,"friends_count":31,"listed_count":1,"favourites_count":0,"statuses_count":417,"created_at":"Mon Jan 26 14:39:13 +0000 2015","utc_offset":7200,"time_zone":"Bucharest","geo_enabled":false,"lang":"en","contributors_enabled":false,"is_translator":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_link_color":"360000","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/559722417979793408\/OsxfkvzX_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/559722417979793408\/OsxfkvzX_normal.png","default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"trends":[],"urls":[{"url":"http:\/\/t.co\/rGi3wwDwmU","expanded_url":"http:\/\/seekingalpha.com\/article\/2899826-going-overweight-with-gilead-in-my-dgi-portfolio?source=twitter_sa_healthinvest","display_url":"seekingalpha.com\/article\/289982\u2026","indices":[49,71]}],"user_mentions":[],"symbols":[{"text":"ABBV","indices":[72,77]},{"text":"BCR","indices":[78,82]},{"text":"BDX","indices":[83,87]},{"text":"JNJ","indices":[88,92]},{"text":"MDT","indices":[93,97]},{"text":"MSA","indices":[98,102]},{"text":"WBA","indices":[103,107]},{"text":"GILD","indices":[108,113]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"low","lang":"en","timestamp_ms":"1423517639663"}
